Equity-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Stock Options Outstanding
Beginning balance (in shares)	5,127,673	2,982,893
Granted (in shares)	0	3,153,641
Vested (in shares)	0	0
Exercised (in shares)	(292,496)	(12,102)
Forfeited (in shares)	(826,308)	(875,410)
Expired (in shares)	(78,267)	(121,349)
Ending balance (in shares)	3,930,602	5,127,673	2,982,893
Vested and exercisable (in shares)	2,006,781
Weighted-Average Exercise Price Per Share
Beginning balance (in usd per share)	$ 2.14	$ 2.89
Granted (in usd per share)	0	2.01
Vested (in usd per share)	0	0
Exercised (in usd per share)	1.44	1.32
Forfeited (in usd per share)	2.35	3.45
Expired (in usd per share)	3.08	7.98
Ending balance (in usd per share)	2.12	$ 2.14	$ 2.89
Vested and exercisable (in usd per share)	$ 2.27
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted-Average Remaining Contractual Life (in years)	8 years 3 days	9 years 10 days	9 years 7 months 20 days
Aggregate Intrinsic Value	$ 10,138	$ 2,209	$ 0
Vested and exercisable, Weighted-Average Remaining Contractual Life (in years)	7 years 10 months 28 days
Vested and exercisable, Aggregate Intrinsic Value	$ 5,121